CN107686546A - A kind of novel degradable polyurethane biomaterial and its preparation method and application - Google Patents
A kind of novel degradable polyurethane biomaterial and its preparation method and application Download PDFInfo
- Publication number
- CN107686546A CN107686546A CN201710462495.3A CN201710462495A CN107686546A CN 107686546 A CN107686546 A CN 107686546A CN 201710462495 A CN201710462495 A CN 201710462495A CN 107686546 A CN107686546 A CN 107686546A
- Authority
- CN
- China
- Prior art keywords
- diisocyanate
- novel degradable
- wound
- block
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004814 polyurethane Substances 0.000 title claims abstract description 79
- 229920002635 polyurethane Polymers 0.000 title claims abstract description 79
- 239000012620 biological material Substances 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 210000000744 eyelid Anatomy 0.000 claims abstract description 33
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 31
- 238000002513 implantation Methods 0.000 claims abstract description 19
- 229920000642 polymer Polymers 0.000 claims abstract description 19
- 230000008439 repair process Effects 0.000 claims abstract description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229920003232 aliphatic polyester Polymers 0.000 claims abstract description 15
- 125000005442 diisocyanate group Chemical group 0.000 claims abstract description 15
- 238000005859 coupling reaction Methods 0.000 claims abstract description 8
- 125000001931 aliphatic group Chemical group 0.000 claims abstract description 5
- 238000006243 chemical reaction Methods 0.000 claims description 15
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 14
- 230000037314 wound repair Effects 0.000 claims description 13
- 150000002148 esters Chemical class 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 7
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- 229920000728 polyester Polymers 0.000 claims description 6
- 239000003054 catalyst Substances 0.000 claims description 4
- 229920001577 copolymer Polymers 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 238000003786 synthesis reaction Methods 0.000 claims description 4
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims description 3
- 239000005057 Hexamethylene diisocyanate Substances 0.000 claims description 3
- 239000005058 Isophorone diisocyanate Substances 0.000 claims description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 3
- 239000004472 Lysine Substances 0.000 claims description 3
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 claims description 3
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 claims description 3
- NIMLQBUJDJZYEJ-UHFFFAOYSA-N isophorone diisocyanate Chemical compound CC1(C)CC(N=C=O)CC(C)(CN=C=O)C1 NIMLQBUJDJZYEJ-UHFFFAOYSA-N 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical class OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 claims description 2
- XLJMAIOERFSOGZ-UHFFFAOYSA-M cyanate Chemical compound [O-]C#N XLJMAIOERFSOGZ-UHFFFAOYSA-M 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
- OWIKHYCFFJSOEH-UHFFFAOYSA-N Isocyanic acid Chemical compound N=C=O OWIKHYCFFJSOEH-UHFFFAOYSA-N 0.000 claims 1
- XLJMAIOERFSOGZ-UHFFFAOYSA-N anhydrous cyanic acid Natural products OC#N XLJMAIOERFSOGZ-UHFFFAOYSA-N 0.000 claims 1
- KORSJDCBLAPZEQ-UHFFFAOYSA-N dicyclohexylmethane-4,4'-diisocyanate Chemical compound C1CC(N=C=O)CCC1CC1CCC(N=C=O)CC1 KORSJDCBLAPZEQ-UHFFFAOYSA-N 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 52
- 210000005036 nerve Anatomy 0.000 abstract description 22
- 210000001519 tissue Anatomy 0.000 abstract description 18
- 230000008929 regeneration Effects 0.000 abstract description 10
- 238000011069 regeneration method Methods 0.000 abstract description 10
- 229920000570 polyether Polymers 0.000 abstract description 8
- 239000004721 Polyphenylene oxide Substances 0.000 abstract description 7
- 239000000126 substance Substances 0.000 abstract description 6
- 150000001875 compounds Chemical class 0.000 abstract description 4
- 238000011084 recovery Methods 0.000 abstract description 4
- 210000004872 soft tissue Anatomy 0.000 abstract description 3
- 150000002009 diols Chemical class 0.000 abstract description 2
- 239000012528 membrane Substances 0.000 abstract description 2
- 238000000059 patterning Methods 0.000 abstract description 2
- 229920000229 biodegradable polyester Polymers 0.000 abstract 1
- 239000004622 biodegradable polyester Substances 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 description 64
- 206010052428 Wound Diseases 0.000 description 61
- 241000700159 Rattus Species 0.000 description 31
- 230000002980 postoperative effect Effects 0.000 description 24
- 210000003625 skull Anatomy 0.000 description 24
- 230000000694 effects Effects 0.000 description 22
- 230000007547 defect Effects 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 13
- 230000006378 damage Effects 0.000 description 13
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 13
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 13
- 239000006260 foam Substances 0.000 description 12
- 230000006870 function Effects 0.000 description 11
- 229920001610 polycaprolactone Polymers 0.000 description 11
- 239000004632 polycaprolactone Substances 0.000 description 11
- 210000000457 tarsus Anatomy 0.000 description 11
- 206010061218 Inflammation Diseases 0.000 description 10
- 230000008602 contraction Effects 0.000 description 10
- 210000001508 eye Anatomy 0.000 description 10
- 230000004054 inflammatory process Effects 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 230000008859 change Effects 0.000 description 8
- 239000007943 implant Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 230000001537 neural effect Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- -1 4,4'- methylene Chemical group 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000001506 calcium phosphate Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 230000035876 healing Effects 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 229920000747 poly(lactic acid) Polymers 0.000 description 6
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 6
- 239000004626 polylactic acid Substances 0.000 description 6
- 229940078499 tricalcium phosphate Drugs 0.000 description 6
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 6
- 235000019731 tricalcium phosphate Nutrition 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 5
- 206010002091 Anaesthesia Diseases 0.000 description 5
- 229920000954 Polyglycolide Polymers 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000037005 anaesthesia Effects 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 210000004209 hair Anatomy 0.000 description 5
- 239000004633 polyglycolic acid Substances 0.000 description 5
- 230000004224 protection Effects 0.000 description 5
- 238000001356 surgical procedure Methods 0.000 description 5
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 5
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 4
- 241000150100 Margo Species 0.000 description 4
- 206010072170 Skin wound Diseases 0.000 description 4
- 238000010171 animal model Methods 0.000 description 4
- 210000005252 bulbus oculi Anatomy 0.000 description 4
- 235000015071 dressings Nutrition 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 229920001432 poly(L-lactide) Polymers 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 210000003497 sciatic nerve Anatomy 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 3
- 206010019196 Head injury Diseases 0.000 description 3
- 206010039509 Scab Diseases 0.000 description 3
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 230000000181 anti-adherent effect Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 210000004087 cornea Anatomy 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000007831 electrophysiology Effects 0.000 description 3
- 238000002001 electrophysiology Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000007489 histopathology method Methods 0.000 description 3
- 239000007928 intraperitoneal injection Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- 238000013508 migration Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 229920001451 polypropylene glycol Polymers 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 238000001291 vacuum drying Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- 208000034530 PLAA-associated neurodevelopmental disease Diseases 0.000 description 2
- 229920000331 Polyhydroxybutyrate Polymers 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 2
- 241000256856 Vespidae Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 230000000735 allogeneic effect Effects 0.000 description 2
- 125000003368 amide group Chemical group 0.000 description 2
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000007822 coupling agent Substances 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 230000004761 fibrosis Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 239000012948 isocyanate Substances 0.000 description 2
- 150000002513 isocyanates Chemical class 0.000 description 2
- 210000003041 ligament Anatomy 0.000 description 2
- 210000002751 lymph Anatomy 0.000 description 2
- AYLRODJJLADBOB-QMMMGPOBSA-N methyl (2s)-2,6-diisocyanatohexanoate Chemical compound COC(=O)[C@@H](N=C=O)CCCCN=C=O AYLRODJJLADBOB-QMMMGPOBSA-N 0.000 description 2
- 230000003562 morphometric effect Effects 0.000 description 2
- 238000013425 morphometry Methods 0.000 description 2
- 230000007659 motor function Effects 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 230000037311 normal skin Effects 0.000 description 2
- 210000000963 osteoblast Anatomy 0.000 description 2
- 230000000278 osteoconductive effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000010827 pathological analysis Methods 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920000903 polyhydroxyalkanoate Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920000909 polytetrahydrofuran Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000012974 tin catalyst Substances 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 description 1
- 208000019300 CLIPPERS Diseases 0.000 description 1
- 208000018380 Chemical injury Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 208000028006 Corneal injury Diseases 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- 241001269524 Dura Species 0.000 description 1
- 206010014568 Empyema Diseases 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 208000005890 Neuroma Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 208000006735 Periostitis Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- UKLDJPRMSDWDSL-UHFFFAOYSA-L [dibutyl(dodecanoyloxy)stannyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[Sn](CCCC)(CCCC)OC(=O)CCCCCCCCCCC UKLDJPRMSDWDSL-UHFFFAOYSA-L 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000036982 action potential Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000003462 bioceramic Substances 0.000 description 1
- 230000000035 biogenic effect Effects 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229960003150 bupivacaine Drugs 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- CWZPGMMKDANPKU-UHFFFAOYSA-L butyl-di(dodecanoyloxy)tin Chemical compound CCCC[Sn+2].CCCCCCCCCCCC([O-])=O.CCCCCCCCCCCC([O-])=O CWZPGMMKDANPKU-UHFFFAOYSA-L 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 1
- 238000005253 cladding Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 229920006237 degradable polymer Polymers 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000012975 dibutyltin dilaurate Substances 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 210000004728 ear cartilage Anatomy 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002389 environmental scanning electron microscopy Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 230000003328 fibroblastic effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 210000001983 hard palate Anatomy 0.000 description 1
- 201000000615 hard palate cancer Diseases 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 210000002239 ischium bone Anatomy 0.000 description 1
- 150000002527 isonitriles Chemical class 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000001095 motoneuron effect Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000004112 neuroprotection Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 210000004409 osteocyte Anatomy 0.000 description 1
- 230000002188 osteogenic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 210000003460 periosteum Anatomy 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 description 1
- 239000005015 poly(hydroxybutyrate) Substances 0.000 description 1
- 229920001306 poly(lactide-co-caprolactone) Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000008263 repair mechanism Effects 0.000 description 1
- 230000000250 revascularization Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 210000004116 schwann cell Anatomy 0.000 description 1
- 210000003786 sclera Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000010148 water-pollination Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/60—Materials for use in artificial skin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/30—Low-molecular-weight compounds
- C08G18/32—Polyhydroxy compounds; Polyamines; Hydroxyamines
- C08G18/3203—Polyhydroxy compounds
- C08G18/3206—Polyhydroxy compounds aliphatic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/42—Polycondensates having carboxylic or carbonic ester groups in the main chain
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/42—Polycondensates having carboxylic or carbonic ester groups in the main chain
- C08G18/4266—Polycondensates having carboxylic or carbonic ester groups in the main chain prepared from hydroxycarboxylic acids and/or lactones
- C08G18/4269—Lactones
- C08G18/4277—Caprolactone and/or substituted caprolactone
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/42—Polycondensates having carboxylic or carbonic ester groups in the main chain
- C08G18/4266—Polycondensates having carboxylic or carbonic ester groups in the main chain prepared from hydroxycarboxylic acids and/or lactones
- C08G18/428—Lactides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/48—Polyethers
- C08G18/4825—Polyethers containing two hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/48—Polyethers
- C08G18/4833—Polyethers containing oxyethylene units
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/48—Polyethers
- C08G18/4854—Polyethers containing oxyalkylene groups having four carbon atoms in the alkylene group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/32—Materials or treatment for tissue regeneration for nerve reconstruction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2230/00—Compositions for preparing biodegradable polymers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Materials For Medical Uses (AREA)
Abstract
Application the present invention relates to a kind of novel degradable polyurethane biomaterial extremely preparation method and in degradable implantation and non-implanted medical device.The new material is the alternating block polyurethane high molecule material obtained based on biodegradable polyester diol and Hydrophilicrto polyether dihydric alcohol, is obtained by the selectively coupled reaction between aliphatic polyester binary alcohol and diisocyanate terminated Hydrophilicrto polyether or between aliphatic poly esterdiol and diisocyanate terminated aliphatic polyester block.Product of the present invention has the polymer chain of controllable and predictable chemical constitution and rule, and there is the patterning structure of surface microfacies, many medical treatment and non-medical instrument field are can be widely applied to, wherein all showing excellent performance in the application such as periphery nerve rehabilitating tube, meniscal repairs, anti-adhesion membrane, meninx, eyelid rebuilding support, wound dressing, the compound porous recovery support of bone, other soft tissues and regeneration of sclerous tissues.
Description
Technical field
The present invention relates to biomedical polymeric material field, particularly a kind of novel degradable polyurethane biomaterial and
Its preparation method and application.
Background technology
Biodegradable block polyurethane is a kind of widely used biomaterial, has had several moneys to plant accordingly at present
Enter medicine equipment and obtain European CE and U.S. FDA approval to be applied to human body.Due to its excellent blood compatibility, excellent
Machinery and processing characteristics, it is widely used in the application necks such as organizational project, regenerative medicine, control medicine delivery, wound healing
Domain.However, almost all of traditional block polyurethane is all using diisocyanate as coupling agent, by dihydric alcohol or/and more
The terminal hydroxyl of first alcohol synthesizes with the coupling reaction of isocyanates, though the material with improved property is this method provide, but
Actually it lacks the permutation and combination of block selectivity and rule, and can only turn into block copolymer by assembly and connection in a random basis
(i.e. traditional random block polyurethane macromolecule, abbreviation:RanPU, as shown in Figure 1), and this kind of random structure will cause material
Property is difficult to regulate and control.
The content of the invention
For overcome the deficiencies in the prior art, the invention provides a kind of novel degradable polyurethane biomaterial and its system
Preparation Method, the material have good blood compatibility, histocompatbility, have excellent surface nature, mechanical mechanics property,
Moulding processability and biodegradability, pH caused by its catabolite are changed very little, and are advantageous to the raising of biocompatibility.
The technical solution adopted for the present invention to solve the technical problems is:
Present invention firstly provides a kind of novel degradable polyurethane biomaterial, including some formed by first polymer
First block, some the second blocks formed by second polymer, the first block and the second block are alternately arranged, and adjacent first
Between block and the second block by carbamate key connection formed alternating block polyurethane (AltPU), as it is described it is new can
Degradable polyurethane biomaterial;
Wherein, the first polymer is the polyester of dihydric alcohol end-blocking, and the second polymer is diisocyanate terminated
Aliphatic polyether or aliphatic polyester polymers, the second polymer can also be substituted by aliphatic dihydroxy alcohol, such as second
Glycol, 1,4- butanediols etc..
Preferably, the polyester of the dihydric alcohol end-blocking combines the copolymerization to be formed for aliphatic polyester or different aliphatic polyesters
Thing.
Preferably, the diisocyanate is aliphatic diisocyanate, specially hexamethylene diisocyanate, fourth two
Isocyanates, lysine diisocyanate, ethyl ester of lysine diisocyanate, IPDI, 4,4'- methylene
One kind in double (cyclohexyl) diisocyanate, the conjunction for the diisocyanate terminated segment in synthesis of selective coupling reaction
Into.
The present invention also provides a kind of preparation method of above-mentioned novel degradable polyurethane biomaterial, with the described first polymerization
Thing and second polymer are reaction raw materials, are reacted 8~72 hours at 30~100 DEG C, obtain the alternating block polyurethane.
Preferably, above-mentioned reaction is carried out in reaction raw materials body or organic solvent, can also be added with reaction system
Machine tin catalyst.
Preferably, hydroxyl is identical with the mol ratio of isocyanate groups in the reaction raw materials.
Above-mentioned novel degradable polyurethane biomaterial is used to be implanted into and the preparation of non-implanted medical device.
Preferably, it is porous to be used for CO2 laser weld socket pipe, meniscal repairs for the novel degradable polyurethane biomaterial
Plate, Antiadhesive film, meninx, eyelid reconstruction support, wound repair film and dressing or the preparation of bone complex repairation support.
The positive effect of the present invention:This is to invent this kind of to there is segment to be alternately arranged the complete of new structure and give birth to for the first time
Thing degraded block polyurethane material.Novel degradable polyurethane biomaterial of the present invention is alternating block polyurethane
(AltPU) a kind of new block polyurethane biomaterial is developed as, it includes being alternately arranged (as shown in Figure 1) for block.
These block polyurethanes have the physics microstructure of controllable chemical constitution and rule.With good controllable chemical constitution
And the surface microstructure of rule, compared with RanPU, AltPU has higher crystallinity, and higher surface energy is more regular
With stable picture on surface.Its alternating structure adds microphase-separated, so as to allow some fragments such as to be moved than more hydrophilic fragment
Move on material surface, so as to possess higher surface energy;Higher crystallinity enhances mechanical strength, and alternating structure causes to have
Well-regulated surface.The roughness on surface is further studied by AFM (AFM), record has identical chemical composition
AltPU and RanPU height image, it is found that 101.8nm Ra (mean roughness) is presented in alternate AltPU material surfaces
With 762.9nm Rmax (maximal roughness), it is significantly larger than the RanPU material tables that Ra is 47.6nm and Rmax is 387.9nm
Face, the patterning structure on these surfaces are advantageous to the adhesion and growth of cell.Alternating block polyurethane (AltPU) of the present invention
Biomaterial not only props up in CO2 laser weld socket pipe, orthopaedics reparation, eyelid rebuilding support, wound dressing and compound porous repair of bone
Good application effect is embodied on frame, in the application of other medicine equipments, including skin reconstruction and reparation, Antiadhesive film, blood
Tubing patch film, meninx, ligament and tendon reparation etc. also embodies excellent repairing performance.
The block alternating structure of alternating block polyurethane of the present invention imparts the much special properties of this material and work(
Energy.Such as traditional PLLA, PLGA and/or based on PCL implantation instrument during degraded, significant change can occur for pH value
(increase acidity), so as to cause the inflammation in local organization, the regeneration function of tissue is influenceed, and can be to the performance of medicine equipment
Have a negative impact.And implantation instrument is only shown during degraded made of the alternating block polyurethane (AltPU) of the present invention
Very small pH value change, the change of its pH value are significantly smaller than raw material such as PCL and corresponding random block polyurethane material
Expect Ran-PU pH value change.Because polyurethane has carbamate chemical structure, it produces acid simultaneously in degradation process
Property carboxyl and alkaline amido, this is different from aliphatic polyester such as PGA and PLA only produces acidic carboxypolymer during degraded, causes fat
The pH of adoption ester implant regional area is significantly reduced, and PLLA, PLGA, and is compared based on implant made of PCL material,
The property of AltPU implants of the present invention pH value minor variations caused during degraded helps to reduce caused by implant
Inflammatory reaction risk, improve the reparative regeneration function of histoorgan.
Brief description of the drawings
Fig. 1:The high molecular schematic arrangement of traditional random block polyurethane;
Fig. 2:The schematic arrangement of alternating block polyurethane of the present invention;
Fig. 3 a:CO2 laser weld micrurgy schematic diagram;
Fig. 3 b:The CO2 laser weld socket pipe being implanted into rat body;
Fig. 3 c:The SEM of the socket pipe prepared by alternating block polyurethane (Alt-PU) schemes;
Fig. 4:Sciatic nerve function index (SFI) value during different materials group CO2 laser weld;
Fig. 5 a:The postoperative 4 weeks rats footprint figure of Alt-PU groups;
Fig. 5 b:The postoperative 8 weeks rats footprint figure of Alt-PU groups;
Fig. 5 c:The postoperative 14 weeks rats footprint figure of Alt-PU groups;
Fig. 6:Different phase electro physiology injury side peak swing and healthy side contrast situation;
Fig. 7 a:The postoperative 1h observations figure of Alt-PU group rats;
Fig. 7 b:The postoperative 24h observations figure of Alt-PU group rats;
Fig. 7 c:Postoperative two weeks observation figures of Alt-PU group rats;
Fig. 7 d:The postoperative surrounding observation figure of Alt-PU group rats;
Fig. 8 a:Gauze group different periods skin ultrastructure compares figure;
Fig. 8 b:Ran-PU group different periods skin ultrastructure compares figures;
Fig. 8 c:Alt-PU group different periods skin ultrastructure compares figures;
Fig. 9:Contraction of wounds rate of each group in the different wound repair times;
Figure 10 a:The histopathological analysis figure of normal skin wound repair;
Figure 10 b:The histopathological analysis figure of Alt-PU group skin ultrastructures;
Figure 10 c:The histopathological analysis figure of gauze group skin ultrastructure;
Figure 11 a:Alt-PU porous foam bone repairing support SEM photographs without hydroxyapatite;
Figure 11 b:Alt-PU porous foam bone repairing support SEM photographs containing 90% percentage by weight hydroxyapatite;
Figure 11 c:Alt-PU porous foam bone repairing support SEM photographs containing 70% percentage by weight hydroxyapatite;
Figure 11 d:Alt-PU porous foam bone repairing support SEM photographs containing 50% percentage by weight hydroxyapatite;
Figure 11 e:Alt-PU porous foam bone repairing support SEM photographs containing 30% percentage by weight hydroxyapatite;
Figure 11 f:Polymetylmethacrylate rack surface SEM photograph without hydroxyapatite;
Figure 12 a:Structure half storey head injury figure on the right side of Rat calvarial;
Figure 12 b:Experimental group stenter to implant defect figure after 18 days;
Figure 12 c:The control group head injury area image of postoperative 40 days;
Figure 12 d:Experimental group implantation support head injury healing image after 80 days.
Embodiment
Below to a preferred embodiment of the present invention will be described in detail, but embodiment the present invention is not done it is any type of
Limit.Reagent and device used in embodiment, all it is using this area common reagent and device unless otherwise specified.
Embodiment 1
Synthesize alternating block polyurethane (Alt-PU) and the poly- ammonia of random block based on aliphatic polyester and Hydrophilicrto polyether
Ester (Ran-PU):
In the organic solvent (chloroform) that aliphatic polyester binary alcohol is initially dissolved in three-neck flask, then it will utilize
Hydrophilicrto polyether-diisocyanate that end capping reaction is prepared, by with dihydric alcohol 1:1 molar equivalent is slowly dropped into flask
In, after reacting 8-72h at 30-100 DEG C, obtain alternating block polyurethane Alt-PU.Above-mentioned reaction also can be directly former in reaction
Carried out in material body, one thousandth can also be used to the organotin catalysts of ten a ten thousandths (weight ratio), such as 2- ethyl hexyls
Sour tin, butyl tin dilaurate etc., hydroxyl and isocyanate groups should have equal mol ratio in reflection system.
By the use of aliphatic polyester binary alcohol and Hydrophilicrto polyether as reacting body, tin-containing catalyst is added, at the same it is different with two
For cyanate as coupling agent, the amount of the diisocyanate of addition is equal to the amount of the material of-OH groups in reaction solution, will react
Mixture stirs 8-72h at 30-100 DEG C under nitrogen protection, then collects product and dries under vacuum to constant weight,
Obtain the random block polyurethane Ran-PU.
The following examples will be with CO2 laser weld socket pipe, eyelid rebuilding support, wound dressing and the compound porous reparation of bone
Support is representative, illustrate the alternating block polyurethane (AltPU) of preparation on applied to implanted medical device with it is other conventional
Degradable biomaterial compares possessed superiority.
Embodiment 2
By the alternating block polyurethane (Alt-PU) prepared in embodiment 1 and random block polyurethane (Ran-PU) biological material
Preparation of the material applied to CO2 laser weld socket pipe:Porous CO2 laser weld socket pipe is prepared by using dip-coating and salt leaching method, used
Then the stainless steel wire that external diameter is 1.5mm air-dries the polymer coating on the mould of gained 2 days, vacuum drying as mould
2 days, then salt is leached in deionized water, freeze-drying and the demoulding obtain CO2 laser weld socket pipe.
CO2 laser weld socket pipe, also referred to as nerve rehabilitating tube or CO2 laser weld sheath;It may also be referred to as CO2 laser weld cladding
Piece and neuroprotection open tube.CO2 laser weld socket pipe prepared by the alternating block polyurethane (Alt-PU) has porosity
For the microporous pipeline structure, micropore laminated structure and pore openings pipeline that 10-99% and aperture are 100nm to 500 μm (micron)
Structure.
The CO2 laser weld socket pipe can also include bioactive substance, such as reactive protein RGD, nerve growth
The factor (NGF), nerve growth medicine, schwann cell and other neural benefit materials.
Peripheral nerve defect is very common clinical wound, and frequently result in patient sensation and motor function forever
Long property is disabled, and 900,000 new cases are there are about every year in China.Nerve autograft is the conventional treatment means of neurotrosis, so
And this method has the size between many shortcomings, including defect nerve and Nerve Graft to mismatch;For extracting the god of donor
Through second operation to be undergone;Donor graft is insufficient;Donor site is also easy to produce neuroma etc..In order to overcome these problems,
Biodegradable CO2 laser weld socket pipe repairs alternative means as effective, for promoting neurotrosis to regenerate and providing god
Path through growth.
The CO2 laser weld socket pipe having been commercialized at present is generally by the type i collagen and synthesized degradable biology material of biological source
Expect that this two classes material is made, for example, polycaprolactone (PCL), poly- (lactide-co-caprolactone) (PCLLA), PLLA
(PLLA), poly- (D, L- lactic acid-ethanol copolymer) (PLGA) and polyvinyl alcohol (PVA).However, by these biomaterial systems
Following FAQs be present in the CO2 laser weld socket pipe made:
1) too fast degraded, this causes early stage to collapse (a few weeks), or too slow degraded (>8 months, even>1 year), it is adjoint
Incomplete or segment degradation;
2) biocompatibility of material is limited, it is impossible to promotes the growth of nerve cell;
3) inflammation caused by acid degradation products;
4) the flexibility deficiency of neural socket pipe, causes neural residul end during regeneration to be torn from neural socket pipe chamber;
5) cause tube chamber to block and prevent the kink resistance of nerve regneration poor;
6) easily cause fibrosis and extensive inflammation reaction of nerve regneration etc. is presented;
7) rejection etc. is immunized caused by biogenic material.
Due to AltPU material structures and the particularity of function, manufactured nerve trachea effectively overcomes the shortcoming of the above, makes
Obtain restoration effect and be not only better than nerve autograft, nerve socket better than made of the above degradable polymer
The repairing effect of pipe.
The CO2 laser weld socket pipe that will be prepared in the present embodiment, CO2 laser weld experiment is carried out in SD rat animal models,
To neural socket pipe and nerve autograft made of Alt-PU and Ran-PU (embodiment 1), PCL, set made of silicone tube
Adapter carries out the system research of CO2 laser weld and compared, and nerve is evaluated using 80 adult SD rats that weight is 300-350g
Repairing effect.Wherein, Fig. 3 a are CO2 laser weld micrurgy schematic diagram;Fig. 3 b are the CO2 laser weld socket in implantation rat body
Pipe;Fig. 3 c are that the SEM of the socket pipe prepared by alternating block polyurethane (Alt-PU) schemes.
Animal is divided into 5 groups, every group 15.Dimension scale that neural socket pipe makes is similar to autologous nerve, and (internal diameter is about
1.3mm;Wall thickness about 0.4mm), neurotrosis mould is used as by sciatic nerve 12mm defects caused by the surgery excision of nerve fiber
Type, the repairing effect for neural socket pipe are evaluated.Animal is anaesthetized with the yellow Jackets of 50mg/kg body weight, the ischium on right side
Nerve exposure, from the horizontal nerve segment for removing 12mm of big midleg.15mm conduits or the nerve of removal are inserted in near-end in itself
Between distal stump, sutured in each junction with No. 8-0 absorbable PLGA suture.After implantation, No. 5-0 seam is used
Zygonema sutures muscle incision, and with 2-0 silk suture skins.Every rat receives an implant, and at identical interval
Time removes.It is postoperative, by every animal feeding in a cage, ad lib and drinking-water.Concentrate to animal carry out autotomy and
The inspection of contracture sign.In each time interval, sciatic nerve function index, electro physiology and histomorphometry are carried out,
To assess the efficiency of CO2 laser weld.All zooperies are according to ISO10993-2:1992 animal welfares require to carry out.
In predetermined time period (postoperative 2,4,8,10 and 14 weeks), nerve regneration is evaluated by walking orbit analysis.In Fig. 4
Middle more different groups sciatic nerve function index (SFI) value, implantation 14 weeks after in Alt-PU groups observe SFI values be-
24%, recover SFI value -28% higher than autograft group, be much better than -35%SFI the values of Ran-PU groups, and PCL groups, silica gel
The SFI values of pipe group.4,8,14 weeks after surgery implantation Alt-PU nerve socket pipes are respectively illustrated in Fig. 5 a, Fig. 5 b and Fig. 5 c
Animal footprint.As can be seen that at 2 and 8 weeks, footprint image is quite narrow and abnormal, and now motor function is not completely extensive
It is multiple.Marked at the 14th week, footprint image recovers normal, shows that neuromotor function significantly recovers.
Different phase electro physiology injury side peak swing and offside (healthy side) contrast situation are as shown in Figure 6, it can be seen that
AltPU groups just already exceed autotransplantation group on the 4th week.
After implantation 4,8 and 14 weeks, Alt-PU, Ran-PU, autograft, PCL supports, silicone tube C MAP current potential
Signal contrasts (result is as shown in Figure 4).Action potential in Alt-PU, Ran-PU, autotransplantation group and PCL support groups is 4
Zhou Houneng is clearly illustrated, shows that the functional rehabilitation of injured nerve is quick.Current potential becomes stronger after 9 and 14 weeks, shows that nerve is repaiied
Recover lost eyesight aobvious.But surprisingly Alt-PU groups show the signal more stronger than autotransplantation group.This shows new alternating block
Autotransplantation of the CO2 laser weld socket pipe of polyurethane (Alt-PU) with being considered as " goldstandard " in restoration effect is suitable,
It is even better.
Embodiment 3
Alternating block polyurethane (Alt-PU) biomaterial prepared in embodiment 1 is applied to the preparation of eyelid support,
Manufacture method is liquid-solid phase separation and freeze-drying:It is put into beaker, is added organic molten with a certain amount of Alt-PU materials
Agent, until Alt-PU is completely dissolved into clear solution.Solution is poured into stainless steel mould, liquid level thickness is poured into control, will contain
The mould for having solution is placed in 1-10h in -20-0 DEG C of frozen water mixing insulating box, 1-24h in -10-4 DEG C is placed in after taking-up, afterwards
Move in freeze drier and freeze, be freeze-dried 1-24h afterwards, taking-up stainless steel mould, which is put into ambient temperature vacuum drying machine, to be dried
1-48h, the demoulding take out shaped support, support then are cut into 1cm2Support, obtain 0.7mm × 1cm2Eyelid is implanted into support.This eye
Eyelid implantation support have porosity be 10-99% and aperture be 100nm to 500 μm (micron) porous membrane structure.
The processing method of commercialization ADM eyelid supports:ADM is put into lyophilized overnight on freeze drier, from freezing
Taken out on drying machine, support is then cut into 1cm2。
Important appendicle of the eyelid as eye, only possesses the work(of its protection eyeball of complete form and function competence exertion
Energy.With the continuous improvement of social industrialization degree, the various wounds of eye, especially soda acid chemical injury, thermal burn and machinery
The caused eyelid wound of wound increasingly increases.The defect of eyelid skin, muscle, tarsus, papebral conjunctiva is often resulted in after defect of eyelid, no
Only influence attractive in appearance, and exposed property ulcer of the cornea is usually caused due to the exposure of eyeball, and then cause the opacity of the cornea, or even wear
Blind in hole.The damage of eyelid usually requires different materials as tissue substituent to fill up or reinforce the part of damage.Therefore,
There are Various Tissues to be developed the reparation for carrying out eye wounds, including autologous tissue, allosome tissue and artificial organ etc..Its
In, the autologous material such as limited source such as Ear cartilage, hard palate mucous membrane, elasticity and toughness are difficult to meet the requirements, and topography is closed
System is complicated, and operation time-histories length is, it is necessary to second of operative incision;Allohisto compatibility such as allogeneic sclera, Homologous dura etc. are transplanted
Thing is antigenic different from body tissue, serious immune rejection can be nearly all faced after implantation, while local inflammation is anti-
Ying Qiang, material are easily degraded and absorbed.So far, can be very good to be widely used in clinic without a kind of tarsus substitute.
Preferable eyelid substitute should comply with following condition:
1) it is convenient to obtain and preserve.
2) it is easy to be operated in art, only need to simply trim and both can reach operation requirement.
3) price is relatively cheap, and most of patient can afford.
4) there is the hardness similar to physiological tissue, thickness and elasticity.
5) host tissue can be facilitated to grow into, and is merged over time with host, it is difficult to differentiated.
6) immunological rejection caused by is slight, inflammatory reaction is small.
7) it is few to be implanted into infectious-related complication.
8) the effect above can continue for quite a long time, or even all the life.
Meanwhile needed with reference to the specific function of eye, tarsus substitute should also have the surface of relative smooth, twinkle
During will not wear cornea under it, it is basic after implantation to meet face symmetrically and protect the effect of eyeball.
Tarsus is replaced with allogeneic acellular dermal (ADM), all sees that correlative study reports that its effect is more both at home and abroad
Ideal, it is that the relatively broad eyelid of current clinical practice substitutes graft.In recent years, the appearance with organizational project and modern times
The fast development of ophthalmology medical science, the constantly improve of medical science theory, we are with the alternating block polyurethane (AltPU) of the present invention for base
Material, the porous support with ultra microstructure is prepared by liquid-solid phase partition method and substitutes the dynamic of tarsus progress eyelid reconstruction in situ
Thing is tested, and using the strong ADM of clinical practice dominance as control, the foundation of feasibility is obtained from histology and cytology evaluation,
Prove that alternating block polyurethane tarsus timbering material can be used as preferable eyelid substitute to be applied to clinic.
The eyelid prepared in the present embodiment implantation support is subjected to eyelid repairing test in SD rat animal models.Animal
Operation consent, Alt-PU eyelids implantation support is rinsed through sterile saline, be sealed after ultraviolet ventilation irradiation 24h in sterile
Saved backup in centrifuge tube.
The foundation of animal model:SD rats 30, male, body weight 300-350g, are randomly divided into 2 groups, every group 15:①
Alt-PU groups;2. ADM groups.Using 1.0% (w/v) yellow Jackets, intraperitoneal injection of anesthesia (40mg/kg), effective rear preserved skin is used
Shaving machine shaves off eye circumference hair, then the whole preserved skin region of routine disinfection, afterwards at the eyebrow of mouse inject 1% lidocaine and
The mixing of 0.75% Bupivacaine (contains 1:100000 adrenaline) subcutaneous infiltration anesthesia.Parallel eyes-affinity is used flat at away from margo palpebrae 2mm
Tweezer is risen, and two arc incision lines of skin are drawn with black gel ink pen, is marked at the 5mm of canthus both sides at operation opening, then
Do the skin incision of upper eyelid by mark line, separate two otch hypodermis and orbicular muscle of eye to tarsus, after finding out tarsus, with aobvious
Micro- clipper for surgical use wipes out 1mm2Size tarsus tissue, obtain eyelid tarsal defect model.By ready Alt-PU eyelids support and
The corresponding tarsal defect position of ADM eyelid stenter to implant, then with the degradable absorbable suture lines of 8-0 by implant and the tarsus broken ends of fractured bone
The corresponding pin of interrupted suture 2, it is interrupted apposition suture skin of upper eyelid with 6-0 absorbable sutures and hypodermis, about 2 pins, art finishes, hinder
Mouth Pressure bandage.Postoperative SD rats are put into mouse cage, after waiting its anesthesia to wake up, give sub-cage rearing, it is postoperative
The wound location of observation rat whether there is redness, infects, festers daily;Wound pairing situation, whether there is and split and plant piece and come off, cruelly
Dew;Conjunctival surface whether there is damaged and corneal damage;Margo palpebrae whether there is deformation;Whether there is that fornix narrows, eyeball adhesion, eyelid movement are abnormal or
Situations such as dysraphism.
The clinical follow result of Alt-PU groups is as shown in Fig. 7 a-7d:A) postoperative one hour, skin incision was degradable with 7-0
Suture suture is absorbed (shown in Fig. 7 a);B) a small scab is formed within postoperative 24 hours, there is a little slight redness in upper eyelid, does not have
Have and observe that obvious rejection and gangrenous phenomenon occur (shown in Fig. 7 b);C) hair at postoperative two weeks eyelid surgeries starts to give birth to
It is long, without it is congested, ooze out and be observed that (shown in Fig. 7 c) with inflammatory reaction phenomenon;D) postoperative 4 weeks art branch holes portion return to
Preoperative the same, arrow points to operative site (shown in Fig. 7 d).Postoperative 1h, the consciousness of rat all recover normal;Postoperative 24h is shown in mouse
Upper eyelid gently swells, and margo palpebrae suture is in place, and wound pairing is good, and local desiccation is without oozing out, a small amount of scab.Eyelid knot is had no after each group implantation
Film is worn out and corneal epithelial wound, and margo palpebrae organizes nothing without incisura, no hypophasis, otch without oozing out and infecting after implantation
Exposure.It is that 1W, the hair of its art side wound of postoperative 2W start to repair completely after surgery that its scab, which is completely fallen off,.Postoperative 2W and
8W art branch hole portion does not have obvious difference, and during eyelid reparation, their daily life system is normal, and art branch hole portion also acts normally
Eye opening eye closing activity, with normal side eye activity.Occur without significantly rejection, gangrene or inflammatory reaction, it was demonstrated that
Its postoperative eyelid wound recovers rapid, it can be seen that, biomaterial of the invention has fine mechanical flexibility, biodegradable
Property and eyelid soft tissue compatibility, can repair very well tarsus damage.
Embodiment 4
Alternating block polyurethane (Alt-PU) biomaterial prepared in embodiment 1 is applied to the system of wound dressing foam
Standby, preparation method is:Weigh alternating block polyurethane (Alt-PU) biomaterial prepared in 2g embodiments 1 and be dissolved in
In 40mL water, the solution that concentration is 50mg/mL is made into, is sufficiently stirred and is poured into after it is completely dissolved in 90mm culture dish.Again
Precooling 1-24h in -20 DEG C of refrigerator is transferred them to, then transfers them to rapidly in -80 DEG C of low temperature refrigerator and freezes 1-
24h.Quickly be transferred in freeze drier, be freeze-dried after taking-up, taken out after 24h, spongy Alt-PU wounds repair
Multiple foam dressing.This wound repair dressing has that porosity is 10-99% and aperture is the porous of 100nm to 500 μm (micron)
Foaming structure.
Ran-PU wound repairs are prepared using the random block polyurethane (Ran-PU) and the above method prepared in embodiment 1
Foam dressing.
Wound repair is always the focus of current medical domain research, at present, the polyurethane material as wound dressing
Rarely found report is studied, because polyurethane high molecule has waterproof and breathable, moisturizing and the function of preventing bacterium from penetrating into, with degradable
PLA and biocompatibility it is good PEG synthesis polyurethane there are good potentiality as the research of wound dressing.The present invention
PLA, PEG group biodegradable polyurethane material are applied to wound repair first, by the full thickness skin for building SD rats
Model, control is used as using hospital gauze.Animal test results show:The repairing effect of biomaterial group of the present invention is substantially better than doctor
With gauze, there are application and commercial value well as a kind of new wound dressing materials.
The Alt-PU wound repairs foam dressing prepared in the present embodiment is carried out into wound in SD rat animal models to repair
Retrial is tested.
By building the full thickness skin trauma model of rat, to evaluate the novel degradable polyurethane biomaterial of the present invention
Curative effect as wound dressing to wound.18 rats (about 300 g) are divided into three groups by random, and every group six is only used as putting down
Row experiment.Intraperitoneal injection of anesthesia agent (10% chloraldurate), dosage 3ml/kg.The hair of area will be tested needed for rat back
Number is cleaned with gently being struck off after 70% alcohol disinfecting with clear water.Then with the surgical scissors after sterilization cut at back 10mm ×
10mm wound size, and the surface of a wound thoroughly expand and created, the surface of a wound, the surface of a wound are cleaned repeatedly with sterile saline and Iodophor liquid
Thoroughly hemostasis.The area of original wound is recorded with the ruler after sterilizing, and photographs to record data.Experimental group is Alt-PU wounds
Foam dressing group is repaired, with Ran-PU wound repair foam dressing groups and hospital gauze as a control group.Change once within every two days
Dressing, wound size is recorded with ruler, and photograph to record wound situation.After ten days, remaining four days no longer more change dressingses, record
14 days data for repairing the phase.Contraction of wounds rate is calculated using following formula:Contraction of wounds rate (%)=[(Ao-At)/Ao] ×
100.Wherein Ao is the area of original wound, and At is the wound area in different reparation periods.
After Skin Wounds, wound recovery situation is observed and recorded by way of taking pictures, as a result such as Fig. 8 a-8c
It is shown.It can be found that the skin wound of three groups of rats has a different degrees of contraction, i.e. the skin of edge of wound is to wound center
Mobile, the surface of a wound reduces, and this means that wound is constantly healing.The 4th day after wound, the surface of a wound of gauze group and Ran-PU groups all goes out
Show inflammatory exudate and clot, and the wound surface of Alt-PU groups does not have the phenomenon of inflammation, redness and empyema.The 8th after wound
My god, the incrustation of gauze group wound, contraction of wounds is slow, and Ran-PU groups still have a small amount of hydrops and blood, but contraction of wounds is better than yarn
Cloth group, the surface of a wound of Alt-PU groups have the granulation tissue of new life, the result shows the recovery of the skin of Alt-PU groups is most fast, have entered
The last repairing phase of skin is entered, so as to which the repairing effect than first two groups will be good.The 14th day after wound, gauze group still has ratio
Obvious scar, shrinkage factor now is only that the contraction of wounds rate of 40%, Ran-PU groups can reach 80%, and Alt-PU groups
Skin substantially healed completely, and surface is grown with hair, it is difficult to it was observed that the scar of wound.Wherein Fig. 9 is
Wound records wound size, and the contraction of wounds rate as obtained by calculating formula, contraction of wounds rate during reparation, with ruler
It is bigger, illustrate that the surface of a wound is smaller, it is also better to recover.It can be seen that the shrinkage factor of Alt-PU groups is always above other two in Fig. 9
Control group, this result are also consistent with result above.
It was found from gross examination of skeletal muscle, polyurethane biomaterial of the invention can provide the effect of protection for wound, and have
Certain acts on every bacterium, the surface of a wound of a moistening can be formed by absorbing diffusate, there is provided give cambium one good life
Long environment.Very close, the Ke Yitong additionally, due to the ammonia ester bond in polyurethane macromolecular and the amido link in people's vivo protein
Cross to the specific effect of cell surface and promote the adhesion and growth of cell, accelerate the healing of wound.Along with suitable parent
Hydrophobicity, mechanical property and pliability etc. all have an impact to wound reparation, and alternating block polyurethane of the invention can turn into
The ideal material of wound repair and skin repair.
The histology pathological analysis of wound repair:In order to further determine that the situation of skin repair, we took at 14 days
Lower neoplastic skin tissue, pathological analysis is carried out to tissue by HE dyeing, as a result as shown in Figure 10 a-10c.As above created
Hinder described in repair mechanisms, be inflammatory reaction first after skin wound is formed, it is the basis of wound healing.This stage master
Have substantial amounts of inflammatory cell, it by phagocytosis, the oxidation effect such as antimicrobial effect and activating complement remove slough and
Foreign matter, normal structure is protected, prevents infection.Followed by fibroblastic a large amount of propagation, it is main repair cell,
The engineer, builder and keeper of wound repair, it is with extracellular matrix, contraction of wounds, the renewal of collagen and paralysed trace
Formation has close relationship.Finally enter back into the regeneration of the organs such as blood vessel and lymph, i.e. regeneration and revascularization.From
Contrast and find in figure, substantial amounts of fibroblast (shown in Figure 10 c) occurs in the wound of gauze group, mainly also in the second of reparation
Stage.And the wound of Alt-PU groups can see the organs such as the new vessels of many, lymph generation (Figure 10 b under the microscope
It is shown), the institutional framework (Figure 10 a shown in) of closer normal skin substantially smaller than gauze group into fibrosis region, this
Phenomenon also can promote migration of epithelial cells relevant with PEG in component.From pathological examination, Alt-PU groups are proved again (alternately
Polyurethane material group) repairing effect be significantly better than gauze group.
Embodiment 5
It is porous that alternating block polyurethane (Alt-PU) biomaterial prepared in embodiment 5 is applied to skull complex repairation
The preparation of support, preparation method are:The Alt-PU alternating block polyurethane biomaterials prepared in appropriate embodiment 1 are weighed, are put
Enter in 20ml vials, add DMF to polyurethane and be completely dissolved.Weigh the sodium chloride of certain particle diameter
Grain, hydroxyapatite (HA) and tricalcium phosphate (TCP) are added in polyurethane solutions after shaking mixing in proportion, and vibration mixes, will
Mixture is coated on slide, and drying at room temperature 48h is complete to DMF volatilization.Slide is placed in ultra-pure water
Middle 24h fully dissolves sodium chloride particle, changes liquid once per 8h, slide is placed in into drying at room temperature 48h in vacuum drying chamber, produced
Alt-PU skull complex repairation porous supports, this support have that porosity is 10-99% and aperture is 100nm to 500 μm (micro-
Rice) porous foam structure.It is easy to the reference of support to contrast simultaneously, we also using polymethyl methacrylate (PMMA) and exist
In the case of there is no HA and TCP, porous support is produced as shown in figure 11f.
Bone tissue engineer research experienced from without immunologic function animal to small-sized mammalian, then to large mammal,
Most Zhongdao clinical stage, its validity, security be proved more and more, its basic fundamental relative maturity.It is careful planting
In terms of born of the same parents, in addition to currently used BMSCs, also occur adipose-derived and Cord Blood-Derived stem cell successively, it
Wide material sources, osteogenic ability be similar to even better than BMSCs.In terms of timbering material, except previously wide variety of different
Beyond body bone holder material, occurs timbering material that is a large amount of artificial and naturally extracting at present, it is wide that these materials are respectively provided with source
General and degradable characteristic, needs of its mechanical strength all close to tissue engineered bone.In terms of constructing technology, work is largely organized
The appearance of journey bone bioreactor, the structure for the tissue engineered bone of specific demand provide possibility.Along with bone tissue engineer
The continuous maturation of technology and product, extensive clinical practice are possibly realized.
The Tissue Engineering Study of bone is concentrated mainly on two aspects at present:
First, bone tissue induces:Defect is filled using a kind of porous, biodegradable stent.This support has self-bone grafting
And osteoconductive potential, the other cells of Gegenbaur's cell and the region can be triggered to grow into and be adsorbed on support.As matrix is accumulated, bone
Tissue gradually forms, and again moulding.Because it has the potentiality of healing and remodeling, make the poroid material of non-organic combination with group
Knit and grow into the bone tissue to form organic structure.This kind of material mainly has bioceramic and poly- fumaryl propylene (PPF).
Second, cell delivery:Autologous osteoblasts cell in osteoconductive scaffold or the healing tool into osteoblast for Cranial defect
There is an important function, Gegenbaur's cell transplanting contributes to bone tissue to grow into be formed with extracellular matrix.Transplanted cells can discharge wide spectrum
Growth factor promotes self-bone grafting and osteanagenesis;Poly α-hydroxylation ester is a kind of up-and-coming cell delivery material.It is other to have
The material of transfusion cell function has PLA (PLA), polyglycolic acid (PGA) and the bifunctional polymerizable of PLA and polyglycolic acid
Thing.
Alternating block polyurethane (AltPU) biomaterial using the present invention is the main material of skull regeneration recovery support
Material, it is blended with the hydroxyapatite and tricalcium phosphate of different content, using percolation of saltouing, the three-dimensional for preparing loose structure is answered
Timbering material is closed, internal stent has high porosity, is mutually communicated between micropore, disclosure satisfy that cell proliferation apoptosis and tissue fluid
Infiltration exchange, is advantageous to the transport of nutriment and metabolite.This support has good blood compatibility and cytocompatibility
Property.It is fine that support repairs Rat calvarial damage effect:It has been shown that, prop up from morphometric evaluation this support reparation Rat calvarial damage results
Frame can keep more complete three-dimensional porous rack profile in reparation early and middle portion, and internal microcellular structure can be that cell is bred
Space is provided with migration, the support of later stage higher HA/TCP contents repair skull can damage quickly, and timbering material is also complete
Degraded, is substituted, appearance is no different with normal bone by area of new bone, it was demonstrated that biomaterial of the invention and thus bone made from material is repaiied
Multiple support can effectively support the effect of skull regeneration reparation.
The foundation of Rat calvarial damage model:The chloraldurate of adult SD rats (300-350g) 10% presses 0.35ml/100g
Body weight intraperitoneal injection of anesthesia, head unhairing, iodine tincture disinfection, calvarium skin 1cm otch, blunt separation periosteum and its surrounding tissue,
Half storey 5x5mm skull defecis are manufactured on the right side of skull with cranial drill, it is compound to be implanted into Alt-PU skulls manufactured in the present embodiment respectively
Repair porous scaffold (experimental group) and HA/TCP compound cranial bones porous support (control group), and fixed support, seam concurrent disinfection wound
Mouthful, injection penicillin (400000IU/ml, 0.2ml/kg) continues 7 days, is implanted into and took skull to carry out after 18 days, 40 days and 80 days
Morphological observation and pathological staining observation, the Alt-PU skulls of the different HA contents of ESEM (SEM) the observation display present invention
Complex repairation porous support internal structure is as shown in Figure 11 a-11e.
Pathological observation and coloration result show:Postoperative 18 days, the skull defeci region of control group was without significant change;In support
In the experimental group of implantation, cell has dissociated into inside skull porous support and starting to breed, cell it is loose be distributed in support
Inside, osteocyte and osteoclast substantially show, and have more New born formation.Postoperative 40 days, control group skull defeci region
Without significant change;Experimental group internal stent cell showed increased, new bone largely generate, and skull defeci region is in closure trend;Portion
Experimental group skull defeci region is divided almost to close completely.Postoperative 80 days, it is new that the defect area of control group grows a thin layer
Bone, in skull porous support group, defect is healed completely, and support is all degraded.Skull porous support (the experiment of the present invention
Group) repair Rat calvarial damage effect it is fine.Rat calvarial damage results are repaired from morphometric evaluation experiment pack support to show:Branch
Frame can keep more complete three-dimensional porous rack profile in reparation early and middle portion, and internal microcellular structure can be that cell is bred
Space is provided with migration, skull porous support repair skull can damage quickly, and the timbering material later stage is also completely degraded quickly,
Substituted by area of new bone, appearance is no different with normal bone, it was demonstrated that this timbering material can effectively support the effect of skull regeneration reparation.
Rat calvarial injury repair:The half storey skull defeci region of mouse is substantially observed from Figure 12 a.Alt-PU supports are planted
After entering defect 18 days, support form can be substantially observed, it is attached at defect, is surrounded by one layer of fibr tissue
(shown in Figure 12 b).40 days after surgery, the skull defeci region of control group was without obvious healing phenomenon (shown in Figure 12 c).Implantation
After Alt-PU supports 80 days, Alt-PU supports have been completely degraded, and (Figure 12 d institutes are repaired in skull defeci region by complete
Show).
It is other one exemplary embodiments below, any type of limitation is not done to the present invention.
Embodiment 6:A kind of alternating block polyurethane (AltPU) is provided, it is a kind of copolymer, including one or two kinds of fat
Fat race polyester segment, such as PLA, PHA, PHB, PCL, PCLLA, PLGA;A hydrophilic segment, such as poly- second can be included simultaneously
Glycol (PEG), polypropylene glycol (PPG), polytetramethylene glycol (PBG), PolyTHF (PTHF) or ethylene glycol, propane diols, butanediol
Small molecule dihydric alcohol, trimethylolpropane (TMP) polyalcohol, it is amphipathic so as to obtain, that is, it is provided simultaneously with hydrophily and hydrophobicity
Copolymer.
Embodiment 7:A kind of alternating block polyurethane (AltPU) is provided, it passes through aliphatic polyester binary alcohol and two isocyanides
Hydrophilicrto polyether the segment such as PEG, PPG, PBG or aliphatic polyether glycol and diisocyanate terminated fat of acid esters end-blocking
It is prepared by the selective coupling reaction between fat race polyester diol segment.Aliphatic polyester binary alcohol segment can be PLA, PHA,
PHB, PCL, PGA, PCLLA, PLGA.Aliphatic diisocyanate used is hexamethylene diisocyanate, the isocyanide of lysine two
Acid esters, fourth diisocyanate, IPDI, 4,4'- di-2-ethylhexylphosphine oxides (cyclohexyl) diisocyanate etc., for closing
Into the diisocyanate terminated segment in selective coupling reaction;Selective coupling reaction is by tin catalyst such as 2- ethyl hexyls
Sour tin (II), butyl are dibutyltindilaurate catalyzed or without using catalyst;Under an inert atmosphere in body or organic molten
Selective coupling reaction is carried out in agent.
Embodiment 8:A kind of alternating block polyurethane is provided, it is the poly- ammonia of alternating block based on aliphatic polyester and polyethers
Ester (Alt-PU).
Embodiment 9:The alternating block polyurethane material is in the application of other biomedical sectors, including Bone Defect Repari branch
The application such as frame, skin reconstruction and reparation, Antiadhesive film, vascular repair film, meninx, ligament and tendon reparation.
With the polymer phase ratio of random block polyurethane design, alternating block polyurethane is designed to produce more regular table
Face structure;With the polymer phase ratio of random block polyurethane design, alternating block polyurethane is designed to produce the polymerization of enhancing
Thing is separated.
The alternating block polyurethane (AltPU) has improved medical science, machinery and processing characteristics, while has minimum
Degraded pH changes and the degradation property that can well control.
Alternating block polyurethane material described in embodiment 7 is applied to CO2 laser weld socket pipe, and other soft tissues and hard
Regeneration, implantable medical device and non-implanted medical device.
Above-described is only the preferred embodiments of the present invention, should be understood that the explanation of above example is simply used
In help understand the present invention method and its core concept, the protection domain being not intended to limit the present invention, it is all the present invention
Any modification for being made within thought and principle, equivalent substitution etc., should be included in the scope of the protection.
Claims (8)
- A kind of 1. novel degradable polyurethane biomaterial, it is characterised in that:Including it is some formed by first polymer first Block, some the second blocks formed by second polymer, the first block and the second block are alternately arranged, the first adjacent block And second pass through carbamate key connection between block and form alternating block polyurethane (AltPU), as described novel degradable Polyurethane biomaterial;Wherein, the first polymer is the polyester of dihydric alcohol end-blocking, and the second polymer is diisocyanate terminated fat Fat adoption ether or aliphatic polyester polymers, the second polymer can also be substituted by aliphatic dihydroxy alcohol, such as ethylene glycol, 1,4- butanediols etc..
- A kind of 2. novel degradable polyurethane biomaterial according to claim 1, it is characterised in that:The dihydric alcohol envelope The polyester at end is that aliphatic polyester or different aliphatic polyesters combine the copolymer to be formed.
- A kind of 3. novel degradable polyurethane biomaterial according to claim 1 or 2, it is characterised in that:Described two is different Cyanate is aliphatic diisocyanate, specially hexamethylene diisocyanate, fourth diisocyanate, the isocyanic acid of lysine two In ester, lysine ester diisocyanate, IPDI, 4,4' methylene bis (cyclohexyl) diisocyanate One kind, the synthesis for the diisocyanate terminated segment in synthesis of selective coupling reaction.
- 4. the preparation method of novel degradable polyurethane biomaterial described in a kind of claim 1, with the first polymer and Second polymer is reaction raw materials, is reacted 8~72 hours at 30~100 DEG C, obtains the alternating block polyurethane.
- A kind of 5. preparation method of novel degradable polyurethane biomaterial according to claim 4, it is characterised in that:Institute State reaction to carry out in reaction raw materials body or organic solvent, organotin catalysts can also be added in reaction system.
- 6. a kind of preparation method of novel degradable polyurethane biomaterial according to claim 4 or 5, its feature exist In:Hydroxyl is identical with the mol ratio of isocyanate groups in the reaction raw materials.
- 7. novel degradable polyurethane biomaterial described in claim 1 is applied to implantation and the preparation of non-implantable medical device.
- 8. novel degradable polyurethane biomaterial described in claim 1 is applied to CO2 laser weld socket pipe, meniscal repairs, resisted Adhesion film, meninx, eyelid reconstruction support, wound repair film or dressing or the preparation of bone complex repairation support.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710462495.3A CN107686546A (en) | 2017-06-19 | 2017-06-19 | A kind of novel degradable polyurethane biomaterial and its preparation method and application |
CN201810111018.7A CN108409938A (en) | 2017-06-19 | 2018-02-07 | A kind of novel degradable polyurethane biomaterial and its preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710462495.3A CN107686546A (en) | 2017-06-19 | 2017-06-19 | A kind of novel degradable polyurethane biomaterial and its preparation method and application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107686546A true CN107686546A (en) | 2018-02-13 |
Family
ID=61152683
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710462495.3A Pending CN107686546A (en) | 2017-06-19 | 2017-06-19 | A kind of novel degradable polyurethane biomaterial and its preparation method and application |
CN201810111018.7A Pending CN108409938A (en) | 2017-06-19 | 2018-02-07 | A kind of novel degradable polyurethane biomaterial and its preparation method and application |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810111018.7A Pending CN108409938A (en) | 2017-06-19 | 2018-02-07 | A kind of novel degradable polyurethane biomaterial and its preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN107686546A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108503768A (en) * | 2018-04-26 | 2018-09-07 | 代清燕 | A kind of degradable polyester biomaterial and its application in CO2 laser weld socket pipe |
CN108721771A (en) * | 2018-06-29 | 2018-11-02 | 四川大学 | A kind of subcutaneous silica gel pipe device and application for toy soft tissue regeneration |
CN109851744A (en) * | 2018-12-21 | 2019-06-07 | 苏州为尔康生物科技有限公司 | A kind of degradable polyurethane biomaterial and its preparation method and application |
CN111072911A (en) * | 2019-11-29 | 2020-04-28 | 苏州林华医疗器械股份有限公司 | Super-lubricating catheter material |
CN112292098A (en) * | 2018-06-05 | 2021-01-29 | 科尔尼特视觉有限公司 | Synthetic ophthalmic graft patch |
CN115521430A (en) * | 2021-09-24 | 2022-12-27 | 苏州瑞济诺医疗科技有限责任公司 | Organic metal catalyst, preparation method and application of degradable biological material |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114634641B (en) * | 2022-03-31 | 2023-05-23 | 重庆大学 | Use of porous polymer films with regular pores for producing antiblocking films |
CN118512654B (en) * | 2023-07-27 | 2025-03-07 | 四川大学 | Preparation method of porous scaffold for tissue regeneration |
CN117462769A (en) * | 2023-11-08 | 2024-01-30 | 广州昊毅新材料科技股份有限公司 | Intervention medical degradable adhesive film material and preparation method thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1862188B1 (en) * | 2006-06-02 | 2018-02-28 | Eidgenössische Technische Hochschule Zürich | Porous membrane comprising a biocompatible block-copolymer |
CN101397361B (en) * | 2008-11-03 | 2010-12-08 | 重庆大学 | A kind of multi-block polyurethane shape memory polymer material and preparation method thereof |
CN101885826B (en) * | 2010-07-28 | 2012-03-28 | 重庆大学 | Biodegradable polyurethane material and preparation method based on piperazine block D, L-polylactic acid |
CN102516555A (en) * | 2011-11-24 | 2012-06-27 | 北京旭阳化工技术研究院有限公司 | Biodegradable branched aliphatic polyester multi-block copolymer and preparation method thereof |
CN104387553B (en) * | 2014-11-20 | 2017-06-13 | 浙江大学 | A kind of biodegradable unsaturated polyurethanes material and preparation method thereof |
CN104356345B (en) * | 2014-12-01 | 2017-04-12 | 四川大学 | Fluorescent graft degradable block polyurethane, bone repair material and preparation method thereof |
CN104744661A (en) * | 2015-03-03 | 2015-07-01 | 宁波市医疗中心李惠利医院 | Hydrophilic degradable segmented polyurethane as well as preparation method and application thereof |
CN104788695B (en) * | 2015-05-15 | 2018-03-30 | 山东师范大学 | A kind of preparation method of biodegradable polyurethane film material |
-
2017
- 2017-06-19 CN CN201710462495.3A patent/CN107686546A/en active Pending
-
2018
- 2018-02-07 CN CN201810111018.7A patent/CN108409938A/en active Pending
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108503768A (en) * | 2018-04-26 | 2018-09-07 | 代清燕 | A kind of degradable polyester biomaterial and its application in CO2 laser weld socket pipe |
CN112292098A (en) * | 2018-06-05 | 2021-01-29 | 科尔尼特视觉有限公司 | Synthetic ophthalmic graft patch |
CN108721771A (en) * | 2018-06-29 | 2018-11-02 | 四川大学 | A kind of subcutaneous silica gel pipe device and application for toy soft tissue regeneration |
CN109851744A (en) * | 2018-12-21 | 2019-06-07 | 苏州为尔康生物科技有限公司 | A kind of degradable polyurethane biomaterial and its preparation method and application |
CN109851744B (en) * | 2018-12-21 | 2021-02-05 | 苏州为尔康生物科技有限公司 | Degradable polyurethane biomaterial and preparation method and application thereof |
CN111072911A (en) * | 2019-11-29 | 2020-04-28 | 苏州林华医疗器械股份有限公司 | Super-lubricating catheter material |
CN111072911B (en) * | 2019-11-29 | 2022-02-11 | 苏州林华医疗器械股份有限公司 | Super-lubricating catheter material |
CN115521430A (en) * | 2021-09-24 | 2022-12-27 | 苏州瑞济诺医疗科技有限责任公司 | Organic metal catalyst, preparation method and application of degradable biological material |
CN115521430B (en) * | 2021-09-24 | 2023-10-13 | 苏州瑞济诺医疗科技有限责任公司 | Preparation method and application of organometallic catalyst and degradable biological material |
Also Published As
Publication number | Publication date |
---|---|
CN108409938A (en) | 2018-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107686546A (en) | A kind of novel degradable polyurethane biomaterial and its preparation method and application | |
Bhardwaj et al. | 3D functional scaffolds for skin tissue engineering | |
Fujimoto et al. | In vivo evaluation of a porous, elastic, biodegradable patch for reconstructive cardiac procedures | |
Pedersen et al. | Biodegradable polyurethane scaffolds in regenerative medicine: Clinical translation review | |
ES2672622T3 (en) | Preparation of regenerative tissue frames | |
JP5399891B2 (en) | Oxidized microbial cellulose and uses thereof | |
CN1774460B (en) | Biodegradable polyurethane/polyurea composition | |
JP5478885B2 (en) | Biocompatible and biodegradable porous matrix particularly useful for tissue reconstruction | |
US20110035023A1 (en) | Prosthesis for promoting the in vivo reconstruction of a hollow organ or a portion of a hollow organ | |
JP6195851B2 (en) | Absorbable cellulosic biomaterial and implant | |
WO2011021712A1 (en) | Substratum for supplying cells/tissues, cell/tissue supply material and process for production thereof, method for regeneration of tissues, and process for production of porous material | |
Khosrowpour et al. | Translation Prospects of a Novel ECM‐Silk Fibroin/Alginate 3D‐Printed Scaffold for Treatment of Full‐Thickness Skin Wounds: An in Vitro and in Vivo Study | |
Lo Monte et al. | Biocompatibility and biodegradability of electrospun PHEA-PLA scaffolds: our preliminary experience in a murine animal model | |
US20120157673A1 (en) | Minimal tissue attachment implantable materials | |
KR100644078B1 (en) | Dermal substitute consisting of amnion and biodegradable polymer, the preparation method and the use thereof | |
Kailani et al. | Synthetic biomaterials for skin tissue engineering | |
US20190374676A1 (en) | A cross-linked structure for tissue regeneration and engineering and the method for synthesising same | |
Mathews | Polydioxanone: applications in surgery and tissue engineering | |
Fatima | Membranes Derived from the Extracellular Matrix of the Decellularized Umbilical Cord for Tissue Engineering Applications | |
JP2002065247A (en) | Cell culture substrate | |
Ramesh | DEVELOPMENT AND OPTIMIZATION OF A BIOCOMPATIBLE HYDROGEL FOR SKIN REGENERATION COMPOSITES. | |
Yan | Research on artificial polymer nano-biomaterials in modern exercise rehabilitation treatment of fractures around the knee joint | |
Shafiq | Fabrication of Bilayered Silk Fiber based Electrospun Scaffolds for Dura Mater Regeneration | |
JP2023526504A (en) | Biomaterials comprising at least one elastomeric matrix and non-sulfated polysaccharides and uses thereof | |
송은호 | Advanced polyurethane based composites for biomedical applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180213 |